Medical care of kidney transplant recipients after the first posttransplant year.
暂无分享,去创建一个
A. Djamali | B. Muth | J. Pirsch | R. Muehrer | B. Becker | G. Mourad | Rebecca Muehrer | Arjang Djamali | R Michael Hofmann | Bryan N Becker | Millie Samaniego | Brenda Muth | John Pirsch | Andrew Howard | Georges Mourad | R. M. Hofmann | M. Samaniego | A. Howard
[1] R. Balshaw,et al. New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta‐Analysis , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] M. Suthanthiran,et al. Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations , 2005, Transplantation.
[3] R. Bersin,et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.
[4] G. Choukroun,et al. Benefits of Erythropoietin in Renal Transplantation , 2005, Transplantation.
[5] P. Roderick,et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review , 2004, Transplantation.
[6] R. Oberbauer. Calcineurin Inhibitor Withdrawal from Sirolimus‐Based Therapy in Kidney Transplantation: A Systematic Review of Randomized Trials , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] H. Malluche,et al. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. , 2003, Journal of the American Society of Nephrology : JASN.
[8] T. Louis,et al. Immunosuppression withdrawal in renal transplantation. , 2000, Transplantation proceedings.
[9] F. Locatelli,et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. , 1996, The New England journal of medicine.
[10] B. Kasiske,et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. , 2000, Journal of the American Society of Nephrology : JASN.
[11] R. Wüthrich,et al. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] E. Jones,et al. Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] A. Levey,et al. THE IMPACT OF PRETRANSPLANTATION HEPATITIS C INFECTION ON THE OUTCOME OF RENAL TRANSPLANTATION , 1995, Transplantation.
[14] H. E. Hansen,et al. The Banff 97 working classification of renal allograft pathology. , 1999, Kidney international.
[15] W. Dietz,et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.
[16] G. Opelz,et al. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. , 1998, Kidney international.
[17] A. Melk,et al. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. , 1999, Journal of the American Society of Nephrology : JASN.
[18] K. Scott,et al. Long-term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] Christopher P. Johnson,et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. , 2002, Kidney international.
[20] L. Ruilope,et al. Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study. , 1994, Transplantation proceedings.
[21] A. Djamali,et al. Outcomes in kidney transplantation. , 2003, Seminars in nephrology.
[22] A. Nagler,et al. INCREASED IMPACT OF ACUTE REJECTION ON CHRONIC ALLOGRAFT FAILURE IN RECENT ERA , 2000, Transplantation.
[23] G. Mayer,et al. Proteinuria in the transplanted patient. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] M. Schnitzler. Diabetes Mellitus After Kidney Transplantation in the United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[25] G. Tydén,et al. Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin). , 1998, Transplantation.
[26] J. Adamson,et al. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] J. Schold,et al. Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies? , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[28] H. Goldschmidt,et al. Malignancy in renal transplantation. , 2004, Journal of the American Society of Nephrology : JASN.
[29] M. Ghoneim,et al. WEIGHT GAIN AFTER RENAL TRANSPLANTATION IS A RISK FACTOR FOR PATIENT AND GRAFT OUTCOME , 2004, Transplantation.
[30] F. Cosio,et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. , 2002, Kidney international.
[31] S. Paraskevas,et al. Factors associated with improvement in deceased donor renal allograft function in the 1990s. , 2005, Journal of the American Society of Nephrology : JASN.
[32] V. D’Agati,et al. Angiotensin converting enzyme inhibition in chronic allograft nephropathy , 2002, Transplantation.
[33] H. Auchincloss,et al. Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. , 2000, Journal of the American Society of Nephrology : JASN.
[34] U. Eisenberger,et al. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[36] D. Heisey,et al. Influence of kidney function to the impact of acute rejection on long‐term kidney transplant survival , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[37] C. Newstead. Recurrent disease in renal transplants. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[38] A. Matas,et al. Life satisfaction in renal transplant recipients: preliminary results from the transplant learning center. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[39] R. Gans,et al. Metabolic Syndrome Is Associated with Impaired Long‐term Renal Allograft Function; Not All Component criteria Contribute Equally , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[40] H. Gül,et al. Relationship between plasma Cystatin C and creatinine in chronic renal diseases and Tx-transplant patients. , 2004, Clinical biochemistry.
[41] D. Heisey,et al. Obesity as a risk factor following renal transplantation. , 1995, Transplantation.
[42] M. Arias,et al. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[43] J. Pirsch,et al. Blood pressure control in kidney transplantation: therapeutic implications , 2004, Journal of Human Hypertension.
[44] D. Heisey,et al. Erythropoietin therapy may retard progression in chronic renal transplant dysfunction. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[45] Glomerulonephritis recurrence in the renal graft. , 2001, Journal of the American Society of Nephrology : JASN.
[46] H. Meier‐Kriesche,et al. Death After Graft Loss: An Important Late Study Endpoint in Kidney Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[47] A. Levey,et al. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[48] R. Wolfe,et al. Long-term renal allograft survival: prognostic implication of the timing of acute rejection episodes. , 1997, Transplantation.
[49] R. Colvin,et al. Chronic allograft nephropathy , 2003, Current opinion in nephrology and hypertension.
[50] G. Remuzzi,et al. Proteinuria and phenotypic change of proximal tubular cells. , 2003, Journal of the American Society of Nephrology : JASN.
[51] A. Hartmann,et al. Hypertension after kidney transplantation: are treatment guidelines emerging? , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[52] S. Lemeshow,et al. Patient survival after renal transplantation III: the effects of statins. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[53] E. Shane,et al. Osteoporosis after solid organ transplantation. , 2005, The Journal of clinical endocrinology and metabolism.
[54] D. Nicol,et al. Obesity is Associated with Worsening Cardiovascular Risk Factor Profiles and Proteinuria Progression in Renal Transplant Recipients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[55] D. Coleman,et al. New human papovavirus (B.K.) isolated from urine after renal transplantation. , 1971, Lancet.
[56] G. Klintmalm,et al. Chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.
[57] M. Sayegh,et al. Transplantation 50 years later--progress, challenges, and promises. , 2004, The New England journal of medicine.
[58] C. Kendziorski,et al. Disease progression and outcomes in chronic kidney disease and renal transplantation. , 2003, Kidney international.
[59] I. Macdougall,et al. Intravenous iron sucrose: establishing a safe dose. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[60] R. Rodger,et al. Hypertension, antihypertensive agents and outcomes following renal transplantation , 2005, Clinical transplantation.
[61] I. Holme,et al. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. , 2004, Kidney international.
[62] R. Rubin,et al. Infection in organ-transplant recipients. , 1998, The New England journal of medicine.
[63] P. Randhawa,et al. Effect of Leflunomide and Cidofovir on Replication of BK Virus in an In Vitro Culture System , 2005, Transplantation.
[64] H. Meier‐Kriesche,et al. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. , 2002, Transplantation.
[65] D. Ellison,et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.
[66] D. Abramowicz,et al. Prevalence and Management of Anemia in Renal Transplant Recipients: A European Survey , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[67] Philip F Halloran,et al. Banff 2003 Meeting Report: New Diagnostic Insights and Standards , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[68] P. Friend,et al. Two‐year incidence of malignancy in sirolimus‐treated renal transplant recipients: results from five multicenter studies * , 2004, Clinical transplantation.
[69] Y. Becker,et al. Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients1 , 2003, Transplantation.
[70] Cees van Kooten,et al. Chronic renal allograft rejection: pathophysiologic considerations. , 2005, Kidney International.
[71] J. Chapman,et al. The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.
[72] I. Holme,et al. Fluvastatin Prevents Cardiac Death and Myocardial Infarction in Renal Transplant Recipients: Post‐Hoc Subgroup Analyses of the ALERT Study , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[73] H. Pilmore,et al. Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy , 2002, Clinical transplantation.
[74] A. Levin. Cystatin C, Serum Creatinine, and Estimates of Kidney Function: Searching for Better Measures of Kidney Function and Cardiovascular Risk , 2005, Annals of Internal Medicine.
[75] S. Palmer,et al. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[76] J. Alexander,et al. Gastric bypass in morbidly obese kidney transplant recipients. , 1996, Clinical transplantation.
[77] G. Opelz,et al. Improved Long‐Term Outcomes After Renal Transplantation Associated with Blood Pressure Control , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[78] T. Theruvath,et al. Strategies to improve long-term outcomes after renal transplantation. , 2002, The New England journal of medicine.
[79] G. Jhangri,et al. The stability of the glomerular filtration rate after renal transplantation is improving. , 2003, Journal of the American Society of Nephrology : JASN.
[80] R. Zietse,et al. PROTEINURIA AFTER RENAL TRANSPLANTATION AFFECTS NOT ONLY GRAFT SURVIVAL BUT ALSO PATIENT SURVIVAL , 2001, Transplantation.
[81] D. Greenwood,et al. Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention , 2004, Circulation.
[82] B. Maes,et al. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[83] J. Trotter,et al. Immunosuppression: Evolution in Practice and Trends, 1994–2004 , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[84] K. Rootwelt,et al. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. , 2001, Transplantation.
[85] N. Perico,et al. Routine renin-angiotensin system blockade in renal transplantation? , 2002, Current opinion in nephrology and hypertension.
[86] R. Foley,et al. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. , 2003, Journal of the American Society of Nephrology : JASN.
[87] S. Head,et al. De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at Two Years , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[88] G. Knoll,et al. The Burden of Chronic Kidney Disease in Renal Transplant Recipients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[89] H. Meier‐Kriesche,et al. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2 , 2003, Transplantation.
[90] J. Briggs. Causes of death after renal transplantation. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[91] G. Eknoyan,et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.
[92] J F Burdick,et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. , 1993, Kidney international.
[93] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[94] E. Shane,et al. Osteoporosis after organ transplantation. , 1998, The American journal of medicine.
[95] B. Kiberd,et al. Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population. , 2005, Transplantation proceedings.
[96] J. Fink,et al. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy. , 2001, Kidney international.
[97] F. Berthoux. SECTION IV: Long-term management of the transplant recipient , 2002 .
[98] Bruce Kupelnick,et al. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease , 2004 .
[99] R L Kormos,et al. Does transplantation produce quality of life benefits? A quantitative analysis of the literature. , 1997, Transplantation.
[100] N. Muirhead. Erythropoietin and renal transplantation. , 1999, Kidney international. Supplement.
[101] J. Fink,et al. Late Calcineurin Inhibitor Withdrawal as a Strategy to Prevent Graft Loss in Patients with Suboptimal Kidney Transplant Function , 2004, American Journal of Nephrology.
[102] R. Oberbauer,et al. SIROLIMUS ALLOWS EARLY CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION RESULTING IN IMPROVED RENAL FUNCTION AND LOWER BLOOD PRESSURE1,2,10 , 2001, Transplantation.
[103] P. Keown,et al. Improving quality of life--the new target for transplantation. , 2001, Transplantation.
[104] R. Colvin,et al. Campath‐1H Induction Plus Rapamycin Monotherapy for Renal Transplantation: Results of a Pilot Study , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[105] D. Hricik,et al. Comparative Effects of Sirolimus and Mycophenolate Mofetil on Erythropoiesis in Kidney Transplant Patients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[106] M. Schnitzler,et al. Incidence and predictors of myocardial infarction after kidney transplantation. , 2005, Journal of the American Society of Nephrology : JASN.
[107] J. Soulillou,et al. Immunosuppressive drugs and the risk of cancer after organ transplantation. , 2005, The New England journal of medicine.
[108] M. Schnitzler,et al. Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[109] G. Eknoyan,et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.
[110] F. Valderrábano,et al. Quality of life in end-stage renal disease patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[111] M. Zand,et al. Management of Hyperlipidemia in the Stable Solid Organ Transplant Recipient , 2001 .
[112] Markus Exner,et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. , 2002, Journal of the American Society of Nephrology : JASN.
[113] A. Kazory,et al. Predicting coronary heart disease in renal transplant recipients: a prospective study. , 2004, Kidney international.
[114] P. Terasaki,et al. Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[115] B. Kasiske,et al. Cancer after Kidney Transplantation in the United States , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[116] N. Basri,et al. Diabetes mellitus after renal transplantation. , 1992, Transplantation proceedings.
[117] T. Paavonen,et al. Sirolimus‐Based Therapy Following Early Cyclosporine Withdrawal Provides Significantly Improved Renal Histology and Function at 3 Years , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[118] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[119] J. Fishman. BK virus nephropathy--polyomavirus adding insult to injury. , 2002, The New England journal of medicine.
[120] L. Agodoa,et al. Late urinary tract infection after renal transplantation in the United States. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[121] Junchao Cai,et al. Humoral theory of transplantation: further evidence. , 2005, Current opinion in immunology.
[122] R. Montgomery,et al. Consensus Opinion from the Antibody Working Group on the Diagnosis, Reporting, and Risk Assessment for Antibody-Mediated Rejection and Desensitization Protocols , 2004, Transplantation.
[123] P. Lang,et al. Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors. , 1996, Transplantation.
[124] W. Bennett,et al. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. , 1996, Kidney international.
[125] B. Kasiske,et al. Surrogate Markers for Long‐Term Renal Allograft Survival , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[126] S. Alexander,et al. Late Post‐transplant Anemia in Adult Renal Transplant Recipients. An Under‐recognized Problem? , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[127] K. Kubota,et al. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. , 2005, Kidney international.
[128] N. Greenspan,et al. Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.
[129] P. Terasaki,et al. Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants. , 2003, Clinical transplants.
[130] D. Dunn,et al. Early versus late acute renal allograft rejection: impact on chronic rejection. , 1993 .
[131] R. Ouseph,et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). , 1999, Transplantation.
[132] R. Parasuraman,et al. Rapid Resolution of Proteinuria of Native Kidney Origin Following Live Donor Renal Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[133] R. Foley,et al. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. , 2002, Journal of the American Society of Nephrology : JASN.
[134] B. Kasiske,et al. Hypertension after kidney transplantation. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[135] M. Joffe,et al. Arterial hypertension and renal allograft survival. , 2000, JAMA.
[136] E. Ryan,et al. Prevention of Infection in Adult Travelers After Solid Organ Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[137] B. Kasiske,et al. Hyperlipidemia in solid organ transplantation. , 1997, Transplantation.
[138] S. Palmer,et al. Interventions for preventing bone disease in kidney transplant recipients. , 2005, The Cochrane database of systematic reviews.
[139] W. Leslie,et al. Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate , 2003, Transplantation.
[140] Ethan M Balk,et al. Erratum: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification (Annals of Internal Medicine (2003) 139 (137-147)) , 2003 .
[141] P. Terasaki,et al. Predictive Value of HLA Antibodies and Serum Creatinine in Chronic Rejection: Results of a 2-year Prospective Trial , 2005, Transplantation.
[142] J. Alexander,et al. DIABETIC PATIENTS ON DIALYSIS SHOULD BE TRANSPLANTED , 2004 .
[143] L. Schiffmann,et al. Effects of Parathyroidectomy on Renal Allograft Survival , 2004, Kidney and Blood Pressure Research.
[144] W. Bennett,et al. Cyclosporine nephrotoxicity. , 2003, Seminars in nephrology.
[145] R. Gans,et al. Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[146] Philip F Halloran,et al. Immunosuppressive drugs for kidney transplantation. , 2004, The New England journal of medicine.
[147] M. Fishbein,et al. Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[148] W. Winkelmayer,et al. Pharmacoepidemiology of anemia in kidney transplant recipients. , 2004, Journal of the American Society of Nephrology : JASN.
[149] B. Kasiske,et al. Long‐Term Deterioration of Kidney Allograft Function , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[150] P. Marchetti. New-onset diabetes after transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[151] B. Kasiske,et al. Cardiovascular disease after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.
[152] R. Wolfe,et al. Long-term survival in renal transplant recipients with graft function. , 2000, Kidney international.
[153] T. Warner,et al. Tertiary hyperparathyroidism after renal transplantation: surgical strategy. , 1998, Surgery.
[154] A. Kazory,et al. One‐Year Post‐Transplant Weight Gain is a Risk Factor for Graft Loss , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[155] Bertram L Kasiske,et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. , 2003, Transplantation.
[156] J. Preiksaitis,et al. Guidelines for the prevention and management of infectious complications of solid organ transplantation , 2004 .
[157] A. Kliger,et al. Treatment of Osteoporosis and Osteopenia in Long‐term Renal Transplant Patients with Alendronate , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[158] J. Curtis,et al. Variables affecting weight gain in renal transplant recipients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[159] R. Foley,et al. Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[160] A. Kaider,et al. Parameters associated with chronic renal transplant failure. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[161] B. Brenner,et al. Why is proteinuria an ominous biomarker of progressive kidney disease? , 2004, Kidney international. Supplement.
[162] Lee Hebert,et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[163] J. Millis,et al. Leflunomide for polyomavirus type BK nephropathy. , 2005, The New England journal of medicine.
[164] P. Vereerstraeten,et al. Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection. , 2000, Transplantation.
[165] L. Gesualdo,et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. , 2005, The New England journal of medicine.
[166] S. Hariharan,et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.
[167] Keith C. Norris,et al. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[168] A. Levey. Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[169] M. Denton,et al. Recurrent and de novo glomerulonephritis in the renal allograft. , 2000, Seminars in nephrology.
[170] B. Kasiske,et al. Risk factors for cancer in renal transplant recipients. , 1999, Transplantation.
[171] H. Meier‐Kriesche,et al. Renal transplantation: a half century of success and the long road ahead. , 2004, Journal of the American Society of Nephrology : JASN.
[172] J. Torras,et al. Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts. , 1996, Journal of the American Society of Nephrology : JASN.
[173] R. Wolfe,et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. , 1999, The New England journal of medicine.
[174] C.,et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. , 2003, Transplantation.
[175] R. Muehrer,et al. PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: Life After Transplantation: New Transitions in Quality of Life and Psychological Distress , 2005, Seminars in dialysis.
[176] J. Schold,et al. Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[177] A. Matas,et al. Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis , 2002, Clinical transplantation.
[178] F. Schena,et al. Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. , 2004, Journal of the American Society of Nephrology : JASN.
[179] E. Briganti,et al. Risk of renal allograft loss from recurrent glomerulonephritis. , 2002, The New England journal of medicine.
[180] S. Bartuś,et al. Noncompliance in organ transplant recipients. , 1990, Transplantation.
[181] T. Lehnert,et al. Malignancy after renal transplantation. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[182] W Zidek,et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.
[183] Jukka T Salonen,et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.
[184] N. Perico,et al. Performance of Different Prediction Equations for Estimating Renal Function in Kidney Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[185] F. Locatelli,et al. Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .
[186] R. Mannon. Polyomavirus nephropathy: what have we learned? , 2004, Transplantation.
[187] R. Jindal,et al. Obesity and kidney transplantation. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[188] T. Klimkait,et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. , 2002, The New England journal of medicine.
[189] P. Kuo,et al. A novel approach to the treatment of chronic allograft nephropathy. , 1997, Transplantation.
[190] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[191] G. Borm,et al. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[192] M. Schnitzler,et al. Guidelines for the treatment and management of new‐onset diabetes after transplantation 1 , 2005, Clinical transplantation.
[193] J. Dipiro,et al. RENAL TRANSPLANT PATIENT COMPLIANCE WITH FREE IMMUNOSUPPRESSIVE MEDICATIONS1 , 2000, Transplantation.